{
    "BLAU3.SA": {
        "short_name": "BLAU        ON      NM",
        "long_name": "Blau Farmac\u00eautica S.A.",
        "summary": "Blau Farmac\u00c3\u00aautica S.A., a pharmaceutical company, engages in the production and sale of biological medications in the United States, Colombia, Chile, Peru, Argentina, Uruguay, and Brazil. Its medications cover various therapeutic classes, such as oncology, hematology, nephrology, rheumatology, infectology, anesthesiology, intensive care, general practice, and others. The company was founded in 1987 and is based in Cotia, Brazil.",
        "currency": "BRL",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SAO",
        "market": "br_market",
        "country": "Brazil",
        "state": "SP",
        "city": "Cotia",
        "zipcode": "06705-030",
        "website": "http://www.blau.com.br",
        "market_cap": null
    },
    "HM6A.SG": {
        "short_name": "Hypera S.A. Reg.Shs (Spons.ADRs",
        "long_name": "Hypera S.A.",
        "summary": "Hypera S.A. operates as a pharmaceutical company in Brazil. It offers branded prescription products under the Mantecorp Farmasa, Episol, Predsim, Alivium, Lisador, Rinosoro, Celestamine, Maxsulid, Diprospan, Mioflex-A, and Addera D3 brands; dermo-cosmetics products under the Mantecorp Skincare brands; and consumer health products under the Apracur, Benegrip, Coristina d, Engov, Epocler, Estomazil, and other brands. The company also provides nutrition, sweeteners, and vitamin supplement products under the Tamarine, Vitasay 50+, Biot\u00c3\u00b4nico Fontoura, and Zero-Cal brands; and similar and generic medicines under the Neo Qu\u00c3\u00admica, Torsilax, Neosoro, Doralgina, Flavonid, and Histamin brands. It sells its products through distributors and wholesalers. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. Hypera S.A. was founded in 2001 and is headquartered in S\u00c3\u00a3o Paulo, Brazil.",
        "currency": "EUR",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "STU",
        "market": "dr_market",
        "country": "Brazil",
        "state": "SP",
        "city": "S\u00c3\u00a3o Paulo",
        "zipcode": "05676-120",
        "website": "http://www.hyperapharma.com.br",
        "market_cap": "Mid Cap"
    },
    "HYPE3.SA": {
        "short_name": "HYPERA      ON      NM",
        "long_name": "Hypera S.A.",
        "summary": "Hypera S.A. operates as a pharmaceutical company in Brazil. It offers branded prescription products under the Mantecorp Farmasa, Episol, Predsim, Alivium, Lisador, Rinosoro, Celestamine, Maxsulid, Diprospan, Mioflex-A, and Addera D3 brands; dermo-cosmetics products under the Mantecorp Skincare brands; and consumer health products under the Apracur, Benegrip, Coristina d, Engov, Epocler, Estomazil, and other brands. The company also provides nutrition, sweeteners, and vitamin supplement products under the Tamarine, Vitasay 50+, Biot\u00c3\u00b4nico Fontoura, and Zero-Cal brands; and similar and generic medicines under the Neo Qu\u00c3\u00admica, Torsilax, Neosoro, Doralgina, Flavonid, and Histamin brands. It sells its products through distributors and wholesalers. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. Hypera S.A. was founded in 2001 and is headquartered in S\u00c3\u00a3o Paulo, Brazil.",
        "currency": "BRL",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SAO",
        "market": "br_market",
        "country": "Brazil",
        "state": "SP",
        "city": "S\u00c3\u00a3o Paulo",
        "zipcode": "05676-120",
        "website": "http://www.hyperapharma.com.br",
        "market_cap": "Mid Cap"
    },
    "HYPMY": {
        "short_name": "HYPERA SA",
        "long_name": "Hypera S.A.",
        "summary": "Hypera S.A. operates as a pharmaceutical company in Brazil. It offers branded prescription products under the Mantecorp Farmasa, Episol, Predsim, Alivium, Lisador, Rinosoro, Celestamine, Maxsulid, Diprospan, Mioflex-A, and Addera D3 brands; dermo-cosmetics products under the Mantecorp Skincare brands; and consumer health products under the Apracur, Benegrip, Coristina d, Engov, Epocler, Estomazil, and other brands. The company also provides nutrition, sweeteners, and vitamin supplement products under the Tamarine, Vitasay 50+, Biot\u00c3\u00b4nico Fontoura, and Zero-Cal brands; and similar and generic medicines under the Neo Qu\u00c3\u00admica, Torsilax, Neosoro, Doralgina, Flavonid, and Histamin brands. It sells its products through distributors and wholesalers. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. Hypera S.A. was founded in 2001 and is headquartered in S\u00c3\u00a3o Paulo, Brazil.",
        "currency": "USD",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "PNK",
        "market": "us_market",
        "country": "Brazil",
        "state": "SP",
        "city": "S\u00c3\u00a3o Paulo",
        "zipcode": "05676-120",
        "website": "http://www.hyperapharma.com.br",
        "market_cap": "Mid Cap"
    },
    "OFSA3.SA": {
        "short_name": "OUROFINO S/AON      NM",
        "long_name": "Ouro Fino Sa\u00fade Animal Participa\u00e7\u00f5es S.A.",
        "summary": "Ouro Fino Sa\u00c3\u00bade Animal Participa\u00c3\u00a7\u00c3\u00b5es S.A., together with its subsidiaries, operates in the animal health industry primarily in Brazil. The company operates through Production Animals, Companion Animals, and International Operations segments. It engages in the manufacture and sale of veterinary products, vaccines, and other products comprising anti-inflammatories, antibiotics, anticoccidials, anti-mastitis, ectoparasiticides, endectocides, endoparasiticides, hemoparasiticides, inoculants, therapeutics, and products for cattle, pigs, poultry, sheep, horses, and goats; and veterinary solutions, such as anesthetics, sedatives, anti-inflammatory, antibiotic, antimicrobial, dermatological, ectoparasiticide, endoparasiticide, dermocosmetic, and otological products for dogs and cats. The company also offers vaccines and other veterinary products for production and companion animals. The company was formerly known as A.H.N.S.P.E. Empreendimentos e Participa\u00c3\u00a7\u00c3\u00b5es S.A. Ouro Fino Sa\u00c3\u00bade Animal Participa\u00c3\u00a7\u00c3\u00b5es S.A. was incorporated in 1987 and is headquartered in Cravinhos, Brazil.",
        "currency": "BRL",
        "sector": "Healthcare",
        "industry": "Drug Manufacturers - Specialty & Generic",
        "exchange": "SAO",
        "market": "br_market",
        "country": "Brazil",
        "state": "SP",
        "city": "Cravinhos",
        "zipcode": "14140-000",
        "website": "http://www.ourofinosaudeanimal.com",
        "market_cap": "Small Cap"
    }
}